204 hospitals from central ministries joined AB-PMJAY

People's immune systems deteriorate as they age, making cancer therapies that rely on immune cells difficult to implement. In a new study, researchers from the University of Lausanne (UNIL), the Lausanne University Hospital (CHUV), the Geneva University Hospitals (HUG), and the Ecole Polytechnique Federale de Lausanne (EPFL) show that age-related immune decline has a measurable impact on CAR-T cell therapy, one of the most advanced forms of cancer immunotherapy.

Renowned experts from diverse fields highlighted the urgent need for gender-sensitive healthcare policies and women-centric preventive diagnostics. The key issues they raised in women's health included cancer screening, mental well-being, and the role of integrated diagnostics in early disease detection.

Ahead of World Cancer Day, The Indian Institute of Technology (IIT) Madras on Monday launched Bharat cancer genome atlas.

New research presented at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting reveals that anatomic lung resections, such as lobectomy and segmentectomy, are associated with better long-term survival than wedge resection for patients with early-stage non-small cell lung cancer (NSCLC).

Researchers from Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, discovered that measuring three independent biological markers in a blood sample can better predict the risk of major cardiovascular events over the next three decades than measuring only one.

Discover is available free of cost, democratising access to personalised healthcare and fostering a culture of participatory medicine.

People with stroke may obtain treatment with clot-busting medications based on social characteristics like education, neighbourhood, and employment, according to a new study.

People with depression have higher body temperatures, which suggests that reducing their temperatures may have a mental health advantage, according to a new UC San Francisco research.

Researchers from the University of Auckland, Amsterdam University Medical Center, and Cambridge University Hospitals have successfully treated over ten patients with CRISPR/Cas9 technology, with preliminary findings just published in a leading journal.

Researchers from the University of Auckland, Amsterdam University Medical Center, and Cambridge University Hospitals have successfully treated over ten patients with CRISPR/Cas9 technology, with preliminary findings just published in a leading journal.